Healthcare provider profile · identity verified

Jill L Rabassa, M.D.

Family Practice · CHARLOTTE, NC · NPI 1609849694

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	499	136
Atorvastatin Calcium	Atorvastatin Calcium	450	124
Rosuvastatin Calcium	Rosuvastatin Calcium	341	94
Losartan Potassium	Losartan Potassium	263	78
Omeprazole	Omeprazole	255	78
Levothyroxine Sodium	Levothyroxine Sodium	235	61
Gabapentin	Gabapentin	184	53
Ozempic	Semaglutide	170	36
Hydrochlorothiazide	Hydrochlorothiazide	159	47
Pantoprazole Sodium	Pantoprazole Sodium	136	37
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	135	46
Metformin Hcl	Metformin Hcl	130	43
Albuterol Sulfate Hfa	Albuterol Sulfate	128	44
Metoprolol Succinate	Metoprolol Succinate	126	39
Simvastatin	Simvastatin	118	35
Alprazolam	Alprazolam	105	25
Fluticasone Propionate	Fluticasone Propionate	98	39
Tramadol Hcl	Tramadol Hcl	95	24
Zolpidem Tartrate	Zolpidem Tartrate	91	25
Ezetimibe	Ezetimibe	87	28
Alendronate Sodium	Alendronate Sodium	83	18
Allopurinol	Allopurinol	82	21
Potassium Chloride	Potassium Chloride	80	23
Lisinopril	Lisinopril	76	22
Montelukast Sodium	Montelukast Sodium	74	21
Carvedilol	Carvedilol	71	24
Escitalopram Oxalate	Escitalopram Oxalate	70	18
Glipizide Er	Glipizide	70	23
Furosemide	Furosemide	65	20
Pravastatin Sodium	Pravastatin Sodium	65	17
Tizanidine Hcl	Tizanidine Hcl	65	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	63	13
Metoprolol Tartrate	Metoprolol Tartrate	63	18
Spironolactone	Spironolactone	62	17
Trazodone Hcl	Trazodone Hcl	60	22
Rybelsus	Semaglutide	58	12
Bupropion Xl	Bupropion Hcl	56	15
Hydralazine Hcl	Hydralazine Hcl	54	18
Duloxetine Hcl	Duloxetine Hcl	52	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	13
Metformin Hcl Er	Metformin Hcl	50	17
Citalopram Hbr	Citalopram Hydrobromide	49	11
Meloxicam	Meloxicam	49	19
Paroxetine Hcl	Paroxetine Hcl	49	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	16
Clonazepam	Clonazepam	47	suppressed
Sertraline Hcl	Sertraline Hcl	47	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	14
Prednisone	Prednisone	45	33
Diclofenac Sodium	Diclofenac Sodium	44	18
Eliquis	Apixaban	43	suppressed
Jardiance	Empagliflozin	42	12
Fluoxetine Hcl	Fluoxetine Hcl	41	suppressed
Topiramate	Topiramate	41	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	40	16
Buspirone Hcl	Buspirone Hcl	39	12
Triamcinolone Acetonide	Triamcinolone Acetonide	37	15
Valacyclovir	Valacyclovir Hcl	37	20
Clonidine Hcl	Clonidine Hcl	36	11
Mounjaro	Tirzepatide	36	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	35	suppressed
Atenolol	Atenolol	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	14
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	28	11
Vitamin D2	Ergocalciferol (Vitamin D2)	28	14
Donepezil Hcl	Donepezil Hcl	27	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	25	suppressed
Ibuprofen	Ibuprofen	24	12
Nifedipine Er	Nifedipine	24	suppressed
Finasteride	Finasteride	23	suppressed
Naproxen	Naproxen	23	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	23	suppressed
Glipizide	Glipizide	22	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	21	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Famotidine	Famotidine	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Linzess	Linaclotide	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Colestipol Hcl	Colestipol Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Promethazine Hcl	Promethazine Hcl	16	suppressed
Torsemide	Torsemide	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Glimepiride	Glimepiride	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Cephalexin	Cephalexin	13	11
Estradiol	Estradiol	13	suppressed
Ibu	Ibuprofen	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Colchicine	Colchicine	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Indapamide	Indapamide	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Amoxicillin	Amoxicillin	11	11
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error